ENDOCA Unlocking the secrets of nature

Endoca for Doctors

Medicinal cannabis is still mainly unapproved in Australia, and doctors need to apply to the TGA via the SAS pathways on behalf of their patients to prescribe it legally. The SAS pathways include SAS Category B, which is the most common, and the Authorised Prescriber pathway.

The SAS Category B pathway allows doctors to apply for approval for their patients to use specific medicinal cannabis products on a case-by-case basis. The Authorised Prescriber pathway is for doctors who have experience with medicinal cannabis and wish to prescribe it regularly to their patients.

The TGA has an Online Portal that allows for both TGA and State Health applications (if required) to be submitted simultaneously, making the process more streamlined and easier to access.

Before considering the application process, doctors must first understand the application of medicinal cannabis and how to dose and monitor their patients. They should also ensure that they follow the legal and regulatory requirements set by the TGA when prescribing medicinal cannabis.

It is important to note that while medicinal cannabis may be a treatment option for some patients, it may not be suitable for everyone. Therefore, doctors should carefully evaluate each patient’s individual circumstances and medical history before considering medicinal cannabis as a treatment option.